EDITORIAL: A CLASSIFICATION SYSTEM FOR PROTOCOL DEVIATIONS IN CLINICAL TRIALSWOLF GT; MAKUCH RW.1980; CANCER CLIN. TRIALS; USA; DA. 1980; VOL. 3; NO 2; PP. 101-103Article

INTRAARTERIAL CHEMOTHERAPY OF HEAD AND NECK CANCER: WORTH ANOTHER LOOK.MUGGIA FM; WOLF GT.1980; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1980; VOL. 3; NO 4; PP. 375-379; BIBL. 10 REF.Article

SERUM GLYCOPROTEINS IN HEAD AND NECK SQUAMOUS CARCINOMA: CORRELATIONS WITH TUMOR EXTENT, CLINICAL TUMOR STAGE, AND T-CELL LEVELS DURING CHEMOTHERAPYWOLF GT; CHRETIEN PB; ELIAS EG et al.1979; AMER. J. SURG.; USA; DA. 1979; VOL. 138; NO 4; PP. 489-500; BIBL. 48 REF.Article

SERUM GLYCOPROTEINS AND IMMUNOGLOBULINS IN NASOPHARYNGEAL CARCINOMA I CORRELATIONS WITH EPSTEIN-BARR VIRUS ASSOCIATED ANTIBODIES AND CLINICAL TUMOR STAGEBASKIES AM; CHRETIEN PB; CZAU SIUNG YANG et al.1979; AMER. J. SURG.; USA; DA. 1979; VOL. 138; NO 4; PP. 478-488; BIBL. 58 REF.Article